Crane Co. 10-Q Summary: Q2 2024
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2024. Crane Company operates three reportable segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials. The company completed the separation of its Payment & Merchandising Technologies segment (now Crane NXT, Co.) in April 2023, which is reported as discontinued operations in prior year comparisons. The company is a large accelerated filer.
Key Financial Metrics
| Metric (in millions) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $581.2 | $509.6 | $1,146.5 | $1,023.4 |
| Operating Profit | $96.6 | $63.1 | $186.0 | $140.6 |
| Operating Margin | 16.6% | 12.4% | 16.2% | 13.7% |
| Net Income (Continuing Ops) | $71.6 | $43.3 | $136.4 | $99.2 |
| Diluted EPS (Continuing Ops) | $1.23 | $0.75 | $2.34 | $1.73 |
| Cash & Equivalents | $229.3 | $329.6 (Dec '23) | N/A | |
| Total Debt | $376.9 | $248.5 (Dec '23) | N/A |
Note: Total Debt includes $130.0 million in short-term borrowings and $246.9 million in long-term debt as of June 30, 2024.
Material Changes vs. Prior Period
- Revenue Growth: Q2 2024 sales increased 14.1% year-over-year, driven by an 8.6% increase in core sales (pricing and volume) and a 5.7% contribution from recent acquisitions (BAUM, Vian, CryoWorks).
- Profitability Expansion: Operating profit surged 53.1% in Q2 2024. This was driven by higher pricing net of inflation, strong productivity gains, and the absence of separation-related expenses incurred in the prior year.
- Segment Performance:
- Aerospace & Electronics: Sales up 22.0% and operating profit up 37.6%, fueled by commercial OEM build rates and defense aftermarket demand.
- Process Flow Technologies: Sales up 13.1% and operating profit up 17.6%, supported by acquisitions and core growth in chemical/pharma markets.
- Engineered Materials: Sales declined 8.0% and operating profit dropped 25.5% due to lower volumes in Building Products and Transportation markets.
- Acquisitions: The company completed the acquisition of CryoWorks ($60.7M) in May 2024 and Vian ($102.5M) in January 2024, significantly impacting segment assets and goodwill.
Guidance, Outlook, and Risks
- 2024 Outlook: Management expects full-year sales to increase approximately 11%, driven by 5-7% core growth and ~5% from acquisitions. Operating profit is expected to improve due to productivity, pricing, and operating leverage.
- Segment Outlook:
- Aerospace & Electronics: Sales expected to grow in the mid-teens range.
- Process Flow Technologies: Sales expected to increase ~10%.
- Engineered Materials: Sales and profit expected to be approximately flat.
- Liquidity: The company maintains an $800 million revolving credit facility and a $300 million term loan. As of June 30, 2024, $130 million was drawn on the revolver and $247 million on the term loan. Management believes cash and borrowing capacity are sufficient for operations and pension contributions.
- Risks & Contingencies:
- Environmental: Significant ongoing remediation liability at the Goodyear Site (Arizona), with an estimated gross liability of $18.1 million as of June 30, 2024. Partial reimbursement from the U.S. Government is expected.
- Legal: Involved in product liability litigation regarding a 2021 chemical leak at a LyondellBasell facility; no material loss is currently estimable.
- Market: Exposure to cyclical industries, raw material price fluctuations, and geopolitical tensions affecting defense spending.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of synergies and revenue contributions from the Vian and CryoWorks acquisitions against the 5% sales contribution guidance.
- Engineered Materials Recovery: Monitor the Engineered Materials segment for signs of stabilization in the Building Products and Transportation markets, which are currently underperforming.
- Environmental Liabilities: Track updates on the Goodyear Site remediation timeline and the status of U.S. Government reimbursements to ensure no unexpected cost escalations.
- Working Capital: Review the $186.4 million cash used for operating working capital in the first half of 2024 to ensure it aligns with seasonal inventory build-up and does not signal liquidity strain.
- Debt Covenants: Confirm continued compliance with the 3.50:1.00 net leverage ratio and 3.00:1.00 interest coverage ratio covenants under the credit agreement.